CME Spark

CME Spark is committed to delivering innovative #CME to healthcare providers to support their efforts to deliver high-quality patient-centered care.

[CME Spark @CmeSpark]

Learn more with Dr. #BrianLacy from @MayoClinicGIHep as he discusses diagnosis, treatment, and the importance of communication with your #IBS-C patients. He is joined by an IBS-C patient who shares her experience in this #CME session available online: https://t.co/mAUo4uigqP

[CME Spark @CmeSpark]

Celebrating #CEProfessionalsDay with a glimpse into the rewarding work involved in creating CME programs! @alliance4cehp #hcepday

[CME Spark @CmeSpark]

Unlock the latest insights into Immunoglobulin A Nephropathy (IgAN) with an accredited CME activity, proudly presented by Cleveland Clinic and CME Spark. Access the comprehensive webcast now and elevate your clinical expertise: https://t.co/s72y4DzTfR

[Fight Colorectal Cancer @FightCRC]

Breaking News: The FDA has granted approval of a new treatment option for patients with the BRAF V600E mutation. BRAFTOVI® in combination with cetuximab (ERBITUX®) and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) can now be used as the first-line treatment option for these patients. We hope to continue to see treatment options for BRAF patients continue to grow.

Not only do we celebrate this news, but we urge all patients, especially stage IV patients, to know their biomarkers and make sure they've received biomarker testing. To learn more about this, go to: https://t.co/l3jaGuKmM7

[CME Spark @CmeSpark]

Join the ACCME accredited session at the Endocrine Society’s Clinical Endocrinology Update 2024. Dr. Vanita Aroda and patient Ms. Catarina Perry discuss managing type 2 diabetes with comorbidities, focusing on GLP-1 receptor agonists and SGLT2 inhibitors. https://t.co/mOOqXfxE4Q

[CME Spark @CmeSpark]

Join this CME session with Dr. Eric Jonasch and patient advocate Dewey Stringer as they delve into immunotherapy combos for advanced renal cell carcinoma. Explore more: [https://t.co/3LFifCkXUN] #RenalCellCarcinoma #Immunotherapy

[CME Spark @CmeSpark]

At the end of our #CEU2024 session on #type2diabetes with #comorbidities with @theendosociety, Dr. @arodamd responded to questions from the audience regarding treatment choices:
#pancreatitis #glp1 #diabetes #t2d

[CME Spark @CmeSpark]

Learn more about biomarker testing and selecting appropriate therapies for patients with metastatic #colorectalcancer (#mCRC) in this free #CME presented by Dr. Parikh (@aparna1024): https://t.co/BRJGQjp193

[CME Spark @CmeSpark]

Brian E. Lacy, MD, PhD, FACG, discusses IBS-C in this new #CME program that incorporates the patient perspective
#ibs #irritablebowelsyndrome #constipation #shareddecisionmaking
https://t.co/Xx51YcaZhS

[CME Spark @CmeSpark]

What have clinicians said about this #CME on #IBD with @IBDMD?
"Explains content in an easy to understand way"
"Very helpful, applicable to real world practice"
"Excellent CME. It was great to have a patient interaction as well"
Get started now: https://t.co/J4TAP78wkb

[CME Spark @CmeSpark]

"It is important for clinicians to focus on the symptom burden in PBC, which can be quite severe, and for which there remain suboptimal therapeutic options." - Kris Kowdley, MD

Learn more from Dr. Kowdley in this case-based activity!

https://t.co/Dg8JI8sCVe

#PBC #CME

[CME Spark @CmeSpark]

What is the optimal amount of weight to potentially achieve NASH resolution, fibrosis regression, and steatosis improvement?
Only 39% of learners answered correctly. How does your knowledge of NASH guidelines compare with your peers?

https://t.co/snco47nv0c

#NASH #NAFLD #CME

[CME Spark @CmeSpark]

"The one thing that has made my journey take a different path is the collaborative care that I've received from my current care team" - Catarina Perry, T2DM patient

Learn more in this conversation between Catarina & Dr. Aroda!

https://t.co/RyYT5k2K2a

#T2DM #diabetes #CME

[CME Spark @CmeSpark]

Get the patient's perspective on IBD! Dr. Rubin (@IBDMD) and Dr. Benjamin discuss new data on oral therapies and shared decision making in IBD management.
https://t.co/J4TAP77YuD

#ulcerativecolitis #crohns #IBD #inflammatoryboweldisease #CME

[CME Spark @CmeSpark]

What is the optimal duration after starting UDCA to assess alkaline phosphatase response in patients with PBC? Learn more with Dr. Kowdley!

https://t.co/Dg8JI8sCVe

#pbc #primarybiliarycholangitis #CME #liverdisease

[CME Spark @CmeSpark]

Which patients with NAFLD are at highest risk for adverse outcomes? Find out in this discussion between Dr. Younossi and Tony Villioti, a NASH patient from @KnowledgeNash

https://t.co/snco47nv0c

#NASH #NAFLD #CME

[CME Spark @CmeSpark]

How do GLP-1 receptor agonists improve glucose levels? Learn more with Dr. Aroda!

https://t.co/RyYT5k2K2a

#T2DM #diabetes #GLP1 #CME

[CME Spark @CmeSpark]

Hear the patient's perspective on endometrial cancer in this online activity.

https://t.co/fc6uwCRjeS

#cme #endometrialcancer #uterinecancer #immunotherapy

[CME Spark @CmeSpark]

Your #IBD patient is receiving tofacitinib. Which adverse event should you counsel him on?
Only 35.6% of learners knew the answer. Test your knowledge against your peers!
https://t.co/J4TAP77YuD

#ulcerativecolitis #crohnsdisease #CME

[CME Spark @CmeSpark]

What is the appropriate initial management of a newly diagnosed patient with #PBC? Learn more with @kowdleymd!

https://t.co/Dg8JI8sCVe

#primarybiliarycholangitis #CME